BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28224303)

  • 1. Conjunctival cytologic features in patients with unilateral primary acquired nasolacrimal duct obstruction.
    Yuksel N; Mutlu M; Kilicarslan A; Akcay E
    Int Ophthalmol; 2018 Feb; 38(1):323-326. PubMed ID: 28224303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tear-Film Osmolarity Changes Following Dacryocystorhinostomy in Primary Acquired Nasolacrimal Duct Obstruction.
    Yuksel N; Akcay E; Ayan B; Duru N
    Curr Eye Res; 2017 Mar; 42(3):348-350. PubMed ID: 27419611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conjunctival cytologic features in anophthalmic patients wearing an ocular prosthesis.
    Kim JH; Lee MJ; Choung HK; Kim NJ; Hwang SW; Sung MS; Khwarg SI
    Ophthalmic Plast Reconstr Surg; 2008; 24(4):290-5. PubMed ID: 18645434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tear instability in the fellow eye of unilateral nasolacrimal obstruction and resolution with dacryocystorhinostomy.
    Tıskaoğlu NS; Yazıcı A
    Orbit; 2023 Aug; 42(4):404-410. PubMed ID: 36069079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacrimal Gland Volume Changes in Unilateral Primary Acquired Nasolacrimal Obstruction.
    Yazici A; Bulbul E; Yazici H; Sari E; Tiskaoglu N; Yanik B; Ermis S
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4425-9. PubMed ID: 26193918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conjunctival bacterial flora in nasolacrimal duct obstruction and its changes after successful dacryocystorhinostomy surgery.
    Eshraghi B; Masoomian B; Izadi A; Abedinifar Z; Falavarjani KG
    Ophthalmic Plast Reconstr Surg; 2014; 30(1):44-6. PubMed ID: 24398486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjunctival cicatrizing disease presenting with lacrimal obstruction.
    Satchi K; McNab AA
    Orbit; 2016 Dec; 35(6):321-323. PubMed ID: 27559621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is gastroesophageal reflux disease associated with primary acquired nasolacrimal duct obstruction?
    Mehta S; Ying GS; Hussain A; Harvey JT
    Orbit; 2018 Apr; 37(2):135-139. PubMed ID: 29040001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impression cytology on conjunctiva and cornea in dry eye patients establishes a correlation between squamous metaplasia and dry eye clinical severity.
    Murube J; Rivas L
    Eur J Ophthalmol; 2003 Mar; 13(2):115-27. PubMed ID: 12696629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective controlled study of vapor pressure tear osmolality and tear meniscus height in nasolacrimal duct obstruction.
    Stahl U; Francis IC; Stapleton F
    Am J Ophthalmol; 2006 Jun; 141(6):1051-6. PubMed ID: 16765672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic analysis of 166 patients with primary acquired nasolacrimal duct obstruction.
    Lee-Wing MW; Ashenhurst ME
    Ophthalmology; 2001 Nov; 108(11):2038-40. PubMed ID: 11713075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced tear break-up time in the fellow eye of patients with unilateral primary acquired nasolacrimal duct obstruction.
    Tıskaoğlu NS; Yazıcı A
    Int Ophthalmol; 2023 Mar; 43(3):965-971. PubMed ID: 36053478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dry eye and decreased tear film stability in primary acquired nasolacrimal duct obstruction patients.
    Yu X; Wang K; Hu Y; Meng Z; Li J; Liu Y; Xiao L; Chen M; Li S; Shen Y; Chen R; Liang X
    Int Ophthalmol; 2024 Jun; 44(1):277. PubMed ID: 38916702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of canalicular closure with endonasal dacryocystorhinostomy without intubation in primary nasolacrimal duct obstruction.
    Cannon PS; Chan W; Selva D
    Ophthalmology; 2013 Aug; 120(8):1688-92. PubMed ID: 23642376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of primary acquired nasolacrimal duct obstruction.
    Kashkouli MB; Sadeghipour A; Kaghazkanani R; Bayat A; Pakdel F; Aghai GH
    Orbit; 2010 Feb; 29(1):11-5. PubMed ID: 20302403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of dye disappearance test and tear meniscus height in diagnosis and postoperative assessment of nasolacrimal duct obstruction.
    Roh JH; Chi MJ
    Acta Ophthalmol; 2010 May; 88(3):e73-7. PubMed ID: 20546233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of Endoscopic Dacryocystorhinostomy in Secondary Acquired Nasolacrimal Duct Obstruction: A Case-Control Study.
    Sweeney AR; Davis GE; Chang SH; Amadi AJ
    Ophthalmic Plast Reconstr Surg; 2018; 34(1):20-25. PubMed ID: 27997463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lacrimal Fossa Bony Changes in Chronic Primary Acquired Nasolacrimal Duct Obstruction and Acute Dacryocystitis.
    Ali MJ; Mishra DK; Bothra N
    Curr Eye Res; 2021 Aug; 46(8):1132-1136. PubMed ID: 33583297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphometric Evaluation of Bony Nasolacrimal Canal in a Caucasian Population with Primary Acquired Nasolacrimal Duct Obstruction: A Multidetector Computed Tomography Study.
    Bulbul E; Yazici A; Yanik B; Yazici H; Demirpolat G
    Korean J Radiol; 2016; 17(2):271-6. PubMed ID: 26957913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of fluorescein dye disappearance test in assessment of adults with nasolacrimal duct obstruction.
    Kashkouli MB; Mirzajani H; Jamshidian-Tehrani M; Pakdel F; Nojomi M; Aghaei GH
    Ophthalmic Plast Reconstr Surg; 2013; 29(3):167-9. PubMed ID: 23503058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.